Screener
Rigel Pharmaceuticals RIGL Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The source filing: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026.
- Filed
- Mar 3, 2026, 4:06 PM EST
- Fiscal year
- FY2025
- Accession
- 0001034842-26-000015
| Line item | As of December 31, 2025 | As of December 31, 2024 |
|---|---|---|
| Commitments | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued and outstanding as of December 31, 2025 and 2024 | — | — |
| Common stock, $0.001 par value; 400,000,000 shares authorized; 18,310,934 and 17,710,216 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 18 | 18 |
| Additional paid-in capital | 1,414,322 | 1,393,325 |
| Accumulated other comprehensive income | 181 | 10 |
| Accumulated deficit | (1,023,041) | (1,390,065) |
| Total stockholders’ equity | 391,480 | 3,288 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Rigel Pharmaceuticals's common stock shares issued?
- Rigel Pharmaceuticals (RIGL) reported common stock shares issued of 18.3M in Q4 2025.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.
Ask your AI about Rigel Pharmaceuticals's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude